Facial Sagging After Rapid Weight Loss (GLP-1): Facelift, Fat Grafting or Both?

Facial Sagging After GLP-1 Weight Loss: Lift or Fat?

Rapid weight loss on GLP-1 medications depletes facial fat pads faster than skin can retract, creating hollow cheeks, deeper folds and jawline laxity. A 2025 imaging study measured a 9% median drop in midfacial volume. Once weight is stable, mild deflation may suit fat grafting, marked laxity needs a facelift, and many patients benefit from both.

Why rapid weight loss changes the face

Glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide can reduce body weight in patients with obesity by 15% to 25% on average after about one year [4]. Losing weight rapidly also reduces the superficial and deep fat pads supporting the cheeks, temples and under-eye area. Social media popularized the phrase "Ozempic face", yet clinical reviews clarify that these features reflect rapid facial fat loss and volume deflation rather than a unique drug-specific deformity [2, 3].

Objective imaging now quantifies this change. In a 2025 retrospective cohort study of 20 patients (median age 54 years) who had head and neck CT or MRI before and after GLP-1 prescriptions—averaging 321 days of therapy and 11.0 kg of weight loss—total midfacial volume fell by a median of 9.0%, with superficial volume down 11.0% and deep volume down 7.0% [1]. When fat recedes quickly, especially after age 40 as skin elasticity declines, overlying skin cannot always contract evenly, accentuating nasolabial folds, jowls and neck laxity [3].

Facelift, fat grafting or both: how to tell what you need

Because rapid weight loss affects both volume and skin tension, treatment depends on which change dominates at rest. A systematic review of 23 plastic surgery publications notes that surgical and nonsurgical options each address distinct components of GLP-1-related facial aging [2].

Primary facial changeCommonly considered optionWhat it addressesKey limitation
Hollow temples or flat cheeks with elastic skinFacial fat graftingRestores natural-feeling volume using purified autologous fatDoes not lift heavy jowls or loose neck skin; partial resorption occurs
Pronounced jowls and neck laxity with adequate cheek volumeFacelift (often with neck lift)Repositions deeper support layers and removes surplus skinDoes not refill hollow temples or deflated central cheeks
Both facial deflation and moderate-to-severe skin laxityFacelift with facial fat graftingLifts descended tissues while selectively refilling hollow zones in one sessionRequires stable weight and adequate donor fat
Early, mild hollowing without surgical readinessDermal fillersTargeted office-based volume restoration with minimal downtimeTemporary; overfilling loose skin looks heavy rather than lifted

For a closer comparison, see fat grafting vs fillers and fat grafting for facial depressions.

Why a facelift alone or volume alone can fall short

Trying to fix loose skin purely with volume is a common pitfall. Large volumes of filler or fat in a sagging lower face cannot suspend descended cheek tissues or tighten a loose jawline; instead, excess volume in lax tissues creates a heavy, puffy contour. Conversely, tightening skin on a gaunt face without replacing lost fat can leave cheeks overly flat or taut. Combining deep-layer lifting with conservative facial fat transfer restores jawline definition without over-pulling skin while softening hollow temples and midface contours [3].

Timing surgery: weight stability and GLP-1 anaesthesia precautions

Two prerequisites matter before scheduling surgery after GLP-1 weight loss: weight stability and perioperative anaesthesia planning.

Wait until your weight stabilizes

Operating during active weight loss risks renewed laxity within months, whereas rapid weight regain can alter contours or enlarge grafted fat cells. Reviews on GLP-1 discontinuation highlight high rates of weight regain upon stopping therapy, alongside potential lean-mass loss during treatment [4]. Holding a steady weight for at least three to six months provides a reliable baseline, much as in post-bariatric surgery.

Anaesthesia and delayed gastric emptying

GLP-1 agonists slow stomach emptying, which can increase aspiration risk under sedation or general anaesthesia [2, 3]. Disclose all GLP-1 medications—whether used for weight loss or diabetes—well ahead of surgery so your anaesthesiologist and prescribing physician can coordinate fasting and dosing protocols [2, 3]. Never alter diabetes medication on your own. See preparing for a facelift for broader preoperative checks.

Who is not a good candidate right now?

  • You are still actively losing significant weight or recently adjusted your GLP-1 dose
  • Your weight fluctuates widely after stopping medication
  • You lack sufficient donor body fat for meaningful fat grafting
  • You have uncontrolled medical conditions, nutritional deficiencies or ongoing nicotine use
  • You expect dermal fillers alone to lift pronounced jowls and loose neck skin
  • You have unreviewed prior facial fillers that may need dissolving before lifting

Recovery and realistic expectations

Standalone facial fat grafting typically brings 7 to 10 days of facial swelling and mild donor soreness; part of the transferred fat resorbs naturally, so final volume is assessed around three to six months. Combined with a facelift, swelling peaks in week one, most patients return to casual social life in two to three weeks, and contours refine over three to six months. See best age for a facelift and facial aesthetics for related planning context.

Assoc. Prof. Dr. Yalçın Bayram's approach

Assoc. Prof. Dr. Yalçın Bayram, a specialist in plastic, reconstructive and aesthetic surgery, assesses post-weight-loss facial changes as a whole. Consultations and follow-ups take place at his Nişantaşı practice in Istanbul, and operations take place in a hospital. International patients send facial photos and their weight timeline for his personal preliminary review; the final surgical plan and anaesthesia precautions are confirmed face to face in Istanbul before surgery. He evaluates skin elasticity, jawline and neck descent, volume depletion and donor fat availability together to recommend fat grafting, a facelift, a neck lift or a combined plan.

See international patients and about us, or reach out via contact.

Frequently Asked Questions

Is "Ozempic face" caused by the drug itself or rapid weight loss?

Medical reviews indicate these changes result mainly from rapid weight and fat loss rather than a unique toxic effect on facial skin. Significant rapid weight loss from any cause can deflate facial fat pads and leave loose skin.

How long should my weight be stable before surgery?

Most surgeons recommend holding a stable weight for at least 3 to 6 months before a facelift or facial fat grafting so ongoing weight loss does not create new laxity and weight regain does not alter grafted fat volume.

Can dermal fillers fix facial sagging after GLP-1 weight loss?

Fillers can soften mild cheek or temple hollowing when skin remains elastic, but they cannot remove excess skin or lift heavy jowls and neck laxity; overfilling lax tissues often looks puffy.

Do I need to stop my GLP-1 medication before surgery?

Because GLP-1 agonists delay gastric emptying, perioperative planning is essential before anaesthesia. Inform your surgeon and anaesthesiologist of the exact medication, dose and indication so your prescribing doctor and surgical team set a safe protocol.

Can a facelift and fat grafting be done together?

Yes. Combining a facelift with targeted facial fat grafting in one session is common after weight loss, lifting loose tissues while selectively restoring cheek or temple volume. Suitability is confirmed at consultation.

References

  1. Sharma RK, Vittetoe KL, Barna AJ, Takkouche S, Varelas AN, Yang SF. Radiographic Midfacial Volume Changes in Patients on GLP-1 Agonists. Otolaryngol Head Neck Surg. 2025;173(2):360-366. PMID: 40407186 · DOI: 10.1002/ohn.1209
  2. Daneshgaran G, Shauly O, Gould DJ. "Ozempic Face" in Plastic Surgery: A Systematic Review of the Literature on GLP-1 Receptor Agonist Mediated Weight Loss and Analysis of Public Perceptions. Aesthet Surg J Open Forum. 2025;7:ojaf056. PMID: 40626110 · DOI: 10.1177/87551225221092681
  3. Humphrey CD, Lawrence AC. Implications of Ozempic and Other Semaglutide Medications for Facial Plastic Surgeons. Facial Plast Surg. 2023;39(6):719-721. PMID: 37541662 · DOI: 10.1055/a-2148-6321
  4. Reiss AB, Gulkarov S, Lau R, Klek SP, Srivastava A, Renna HA. Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss. Biomolecules. 2025;15(3). PMID: 40149944 · DOI: 10.1177/15598276241302273

Last reviewed: November 2026


Medical review: This article has been medically reviewed by Assoc. Prof. Dr. Yalçın Bayram, specialist in plastic, reconstructive and aesthetic surgery (Şişli, Istanbul). For his background and academic publications, see about us. This article is for general information; the right approach for you is decided at consultation.